Compare Elder Pharma with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs ALKEM LABORATORIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA ALKEM LABORATORIES ELDER PHARMA/
ALKEM LABORATORIES
 
P/E (TTM) x -0.2 21.9 - View Chart
P/BV x 0.1 5.3 1.9% View Chart
Dividend Yield % 0.0 0.9 -  

Financials

 ELDER PHARMA   ALKEM LABORATORIES
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
ALKEM LABORATORIES
Mar-20
ELDER PHARMA/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs3802,720 14.0%   
Low Rs1881,660 11.3%   
Sales per share (Unadj.) Rs491.2697.9 70.4%  
Earnings per share (Unadj.) Rs-3.296.1 -3.3%  
Cash flow per share (Unadj.) Rs14.4117.3 12.3%  
Dividends per share (Unadj.) Rs025.00 0.0%  
Dividend yield (eoy) %01.1 0.0%  
Book value per share (Unadj.) Rs376.5515.2 73.1%  
Shares outstanding (eoy) m20.54119.57 17.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.63.1 18.4%   
Avg P/E ratio x-89.322.8 -391.8%  
P/CF ratio (eoy) x19.718.7 105.5%  
Price / Book Value ratio x0.84.3 17.7%  
Dividend payout %026.0 0.0%   
Avg Mkt Cap Rs m5,833261,879 2.2%   
No. of employees `000NA14.3 0.0%   
Total wages/salary Rs m2,17915,055 14.5%   
Avg. sales/employee Rs ThNM5,822.6-  
Avg. wages/employee Rs ThNM1,050.5-  
Avg. net profit/employee Rs ThNM802.0-  
INCOME DATA
Net Sales Rs m10,08983,444 12.1%  
Other income Rs m2571,042 24.6%   
Total revenues Rs m10,34684,486 12.2%   
Gross profit Rs m-79214,734 -5.4%  
Depreciation Rs m3612,528 14.3%   
Interest Rs m2,756651 423.7%   
Profit before tax Rs m-3,65312,598 -29.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m1251,105 11.3%   
Profit after tax Rs m-6511,493 -0.6%  
Gross profit margin %-7.817.7 -44.5%  
Effective tax rate %-3.48.8 -39.1%   
Net profit margin %-0.613.8 -4.7%  
BALANCE SHEET DATA
Current assets Rs m9,24054,960 16.8%   
Current liabilities Rs m9,99832,433 30.8%   
Net working cap to sales %-7.527.0 -27.8%  
Current ratio x0.91.7 54.5%  
Inventory Days Days4680 58.2%  
Debtors Days Days6072 83.1%  
Net fixed assets Rs m10,12432,710 31.0%   
Share capital Rs m206239 86.0%   
"Free" reserves Rs m5,58261,368 9.1%   
Net worth Rs m7,73461,607 12.6%   
Long term debt Rs m4,8891,592 307.0%   
Total assets Rs m22,88299,433 23.0%  
Interest coverage x-0.320.4 -1.6%   
Debt to equity ratio x0.60 2,445.8%  
Sales to assets ratio x0.40.8 52.5%   
Return on assets %11.812.2 96.3%  
Return on equity %-0.818.7 -4.5%  
Return on capital %22.321.0 106.4%  
Exports to sales %3.019.1 15.9%   
Imports to sales %0.43.0 14.4%   
Exports (fob) Rs m30715,917 1.9%   
Imports (cif) Rs m432,483 1.7%   
Fx inflow Rs m30716,061 1.9%   
Fx outflow Rs m1252,483 5.0%   
Net fx Rs m18113,578 1.3%   
CASH FLOW
From Operations Rs m11,7545,851 200.9%  
From Investments Rs m-561-7,414 7.6%  
From Financial Activity Rs m-6,762792 -854.3%  
Net Cashflow Rs m4,432-731 -606.2%  

Share Holding

Indian Promoters % 39.6 66.9 59.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 33.1 22.7%  
FIIs % 16.8 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 0.0 -  
Shareholders   16,479 68,381 24.1%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   FRESENIUS KABI ONCO.  TORRENT PHARMA  BIOCON   STERLING BIOTECH  ABBOTT INDIA  

Compare ELDER PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Nifty is Weak but Smallcaps Can Outperform(Momentum Moves)

The market see-sawed during the week with both the bulls and bears swinging it out. But in the end, it was the bears who won. The Nifty ended the day, the week, and the month at 14,529.15.

Related Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Intraday Trading for a Living(Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 8-QTR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS